Cargando…
Prolyl Hydroxylase 3 Knockdown Accelerates VHL-Mutant Kidney Cancer Growth In Vivo
Von Hippel Lindau (VHL) inactivation, which is common in clear cell renal cell carcinoma (ccRCC), leads directly to the disruption of oxygen homoeostasis. VHL works through hypoxia-inducible factors (HIFs). Within this VHL-HIF system, prolyl hydroxylases (PHDs) are the intermediary proteins that ini...
Autores principales: | Zacharias, Niki M., Wang, Lei, Maity, Tapati, Li, Li, Millward, Steven W., Karam, Jose A., Wood, Christopher G., Navai, Neema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001211/ https://www.ncbi.nlm.nih.gov/pubmed/33799686 http://dx.doi.org/10.3390/ijms22062849 |
Ejemplares similares
-
Function and expression of prolyl hydroxylase 3 in cancers
por: Liu, Qiu-long, et al.
Publicado: (2013) -
Inappropriate production of collagen and prolyl hydroxylase by human breast cancer cells in vivo.
por: Al-Adnani, M. S., et al.
Publicado: (1975) -
The role of HIF prolyl hydroxylases in tumour growth
por: Jokilehto, Terhi, et al.
Publicado: (2010) -
Genetically proxied therapeutic prolyl-hydroxylase inhibition and cardiovascular risk
por: Harlow, Charli E, et al.
Publicado: (2022) -
Hypoxia-inducible factor prolyl hydroxylase inhibitors in kidney transplant recipients
por: Ogata, Masatomo, et al.
Publicado: (2022)